Virginia Commonwealth University

VCU Massey Cancer Center

Annual Massey Research Retreat draws record turnout

Research Retreat 2014

On Friday, May 23, the annual Virginia Commonwealth University (VCU) Massey Cancer Center Research Retreat attracted more than 150 attendees to learn about the most promising cancer research being conducted at Massey and throughout VCU.

Continue reading →

New combination therapy eradicates prostate cancer in vivo

Paul Fisher

In their study, published in the journal Proceedings of the National Academy of Sciences, prostate cancer growth in mice with functioning immune systems was inhibited by sensitizing the cancer cells with the drug Sabutoclax (BI-97C1) and using UTMD technology to deliver a viral gene therapy that expresses the genemda-7/IL-24. This powerful new approach to treating prostate cancer builds upon prior studies by principle investigator Paul B. Fisher, M.P.H., Ph.D., Thelma Newmeyer Corman Endowed Chair in Oncology Research at VCU Massey (photo on left). Fisher is professor and chair of the Department of Human and Molecular Genetics in the VCU School of Medicine, and director of the VCU Institute of Molecular Medicine.

Continue reading →

Doctoral student crosses disciplines to develop a new therapy for pancreatic cancer

David Durrant, doctoral candidate in the Department of Biochemistry and Molecular Biology

David Durrant is a doctoral candidate in the Department of Biochemistry and Molecular Biology at the VCU School of Medicine. With guidance from Rakesh Kukreja, M.S., Ph.D., he is making significant progress testing a new combination therapy for pancreatic cancer, and many in the field of pharmacology are taking notice. 

Continue reading →

Holding the promise to improved health care

Alex Krist for blog

Electronic health records (EHRs) hold the promise to improve primary health care for millions of patients. However, enhancing current EHR functionality is needed to better support primary care clinicians and patients, according to a recent article.

Continue reading →

VCU Massey researcher works to develop new cancer-fighting drugs and target therapies

Matthew Hartman, Ph.D., has focused his research on two hot topics in the arena of cancer research: developing drugs that inhibit key cancer proteins and developing better ways to target cancer tumors. He studies how proteins interact with each other on the molecular level.

Continue reading →